3 Biotech

, 7:201 | Cite as

Recombinant production of Aspergillus Flavus uricase and investigation of its thermal stability in the presence of raffinose and lactose

  • Mehdi Imani
  • Serveh Shahmohamadnejad
Original Article


Aspergillus flavus uricase (Rasburicase) with a molecular mass of 135 kDa is currently used for the treatment of gout and hyperuricemia occurring in tumor lysis syndrome. To characterize the effects of raffinose and lactose osmolytes on the uricase structure, its coding sequence was cloned, expressed in E. coli BL21, and purified by Ni–NTA agarose affinity chromatography. Thermal inactivation studies at 40 °C showed that nearly 15% of UOX activity was preserved, while the presence of raffinose and lactose reduced its activity to 35 and 45% of its original activity, respectively. Investigation of UOX thermal stability at 40 °C in the course of time showed that the enzyme relatively lost almost 60% of its original activity after 40 min, whereas more than 50% of UOX activity is preserved in the presence of lactose. Estimation of thermal inactivation rate constant, k in, showed that the UOX k in and UOX k in in the presence of raffinose was unchanged (0.018 min−1), whereas for the presence of lactose, it was 0.015 min−1. Half-life and T m analysis showed that UOX half-life is almost 38 min and addition of raffinose did not change the half-life, whereas the presence of lactose had remarkable impact on UOX half-life (46 min). The presence of raffinose increased UOX T m to a lesser extent, whereas lactose notably enhanced the T m from 27 to 37 °C. Overall, our findings show that lactose has protective effects on UOX stability, while for raffinose, it is relatively compromised.


Uricase Osmolyte Thermal stability Recombinant Aspergillus flavus 



The authors would like to thank the research council of Urmia University for financial support. Technical support from Mr. Ashkan Basirnia and Mrs. Razieh Pak-Tarmani is highly appreciated, as well.

Compliance with ethical standards

Conflict of interest

The authors report no conflicts of interest.


  1. Alakel N, Middeke JM, Schetelig J, Bornhäuser M (2017) Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. OncoTargets Ther 10:597CrossRefGoogle Scholar
  2. Arora K, Choudhary M, Malhotra BD (2014) Enhancing performance of uricase using multiwalled carbon nanotube doped polyaniline. Appl Biochem Biotechnol 174:1174–1187CrossRefGoogle Scholar
  3. Barnett GV, Razinkov VI, Kerwin BA, Blake S, Qi W, Curtis RA, Roberts CJ (2016) Osmolyte effects on monoclonal antibody stability and concentration-dependent protein interactions with water and common osmolytes. J Phys Chem B 120:3318–3330. doi: 10.1021/acs.jpcb.6b00621 CrossRefGoogle Scholar
  4. Bolen DW (2001) Protein stabilization by naturally occurring osmolytes. Methods Mol Biol 168:17–36. doi: 10.1385/1-59259-193-0:017  Google Scholar
  5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefGoogle Scholar
  6. Cammalleri L, Malaguarnera M (2007) Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci 4:83–93CrossRefGoogle Scholar
  7. Caves MS, Derham BK, Jezek J, Freedman RB (2013) Thermal inactivation of uricase (urate oxidase): mechanism and effects of additives. Biochemistry 52:497–507CrossRefGoogle Scholar
  8. De Laet M, Gilis D, Rooman M (2016) Stability strengths and weaknesses in protein structures detected by statistical potentials: application to bovine seminal ribonuclease. Proteins Struct Funct Bioinform 84:143–158CrossRefGoogle Scholar
  9. Dabbagh F, Ghoshoon MB, Hemmati S, Zamani M, Mohkam M, Ghasemi Y (2016) Engineering human urate oxidase: towards reactivating it as an important therapeutic enzyme. Curr Pharm Biotechnol 17:141–146CrossRefGoogle Scholar
  10. Fazel R et al (2014) Cloning and expression of Aspergillus flavus urate oxidase in Pichia pastoris. SpringerPlus 3:395CrossRefGoogle Scholar
  11. Gabison L, Chiadmi M, El Hajji M, Castro B, Colloc’h N, Prangé T (2010) Near-atomic resolution structures of urate oxidase complexed with its substrate and analogues: the protonation state of the ligand. Acta Crystallogr D Biol Crystallogr 66:714–724CrossRefGoogle Scholar
  12. Golabi M, Naem S, Imani M, Dalirezh N (2016) Evidence of morphine like substance and μ-opioid receptor expression in Toxacara canis (Nematoda: Ascaridae). In: Veterinary research forum, vol 4. Faculty of Veterinary Medicine, Urmia University, pp 331–335Google Scholar
  13. Imani M, Zarei Jaliani H, Kheirandish MH, Azadpour M (2017) Recombinant production and affinity purification of the FraC pore forming toxin using hexa-His tag and pET expression cassette. Iran J Basic Med Sci 20:380–385. doi: 10.22038/ijbms.2017.8577 Google Scholar
  14. Kant R, Tabassum R, Gupta BD (2016) Fiber optic SPR-based uric acid biosensor using uricase entrapped polyacrylamide gel. IEEE Photonics Technol Lett 28:2050–2053CrossRefGoogle Scholar
  15. Keilin J (1959) The biological significance of uric acid and guanine excretion. Biol Rev 34:265–294. doi: 10.1111/j.1469-185X.1959.tb01308.x CrossRefGoogle Scholar
  16. Khaksa G, Nalini K, Bhat M, Udupa N (1998) High-performance liquid chromatographic determination of insulin in rat and human plasma. Anal Biochem 260:92–95CrossRefGoogle Scholar
  17. Khan SH, Ahmad N, Ahmad F, Kumar R (2010) Naturally occurring organic osmolytes: from cell physiology to disease prevention. IUBMB Life 62:891–895CrossRefGoogle Scholar
  18. Kratzer JT et al (2014) Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci 111:3763–3768CrossRefGoogle Scholar
  19. Legoux R et al (1992) Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J Biol Chem 267:8565–8570Google Scholar
  20. Li J et al (2006) High-level expression, purification, and characterization of non-tagged Aspergillus flavus urate oxidase in Escherichia coli. Protein Expr Purif 49:55–59CrossRefGoogle Scholar
  21. Mahjoubi N, Fazeli MR, Dinarvand R, Khoshayand MR, Fazeli A, Taghavian M, Rastegar H (2015) Preventing aggregation of recombinant interferon beta-1b in solution by additives: approach to an albumin-free formulation. Adv Pharm Bull 5:497CrossRefGoogle Scholar
  22. Mahler H, HuBSCHER G, Baum H (1955) Studies on uricase. J Biol Chem 216:625–641Google Scholar
  23. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V (2016) Regulation of uric acid metabolism and excretion. Int J Cardiol 213:8–14. doi: 10.1016/j.ijcard.2015.08.109 CrossRefGoogle Scholar
  24. Moussa B, Farouk F, Azzazy H (2010) A validated RP-HPLC method for the determination of recombinant human insulin in bulk and pharmaceutical dosage form. J Chem 7:S449–S457Google Scholar
  25. Pascual E, Pedraz T (2004) Gout. Curr Opin Rheumatol 16:282–286CrossRefGoogle Scholar
  26. Pasut G, Sergi M, Veronese FM (2008) Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv Drug Deliv Rev 60:69–78CrossRefGoogle Scholar
  27. Pession A, Melchionda F, Castellini C (2008) Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase). Biologics 2:129–141Google Scholar
  28. Pui C-H et al (2001a) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19:697–704CrossRefGoogle Scholar
  29. Pui C, Jeha S, Irwin D, Camitta B (2001b) Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia 15:1505–1509CrossRefGoogle Scholar
  30. Ranga R, Sarada A, Baskaran V, Ravishankar GA (2009) Identification of carotenoids from green alga Haematococcus pluvialis by HPLC and LC-MS (APCI) and their antioxidant properties. J Microbiol Biotechnol 19:1333–1341Google Scholar
  31. Retailleau P et al (2004) Complexed and ligand-free high-resolution structures of urate oxidase (Uox) from Aspergillus flavus: a reassignment of the active-site binding mode. Acta Crystallogr D Biol Crystallogr 60:453–462CrossRefGoogle Scholar
  32. Retailleau P, Colloc’h N, Vivares D, Bonneté F, Castro B, El Hajji M, Prangé T (2005) Urate oxidase from Aspergillus flavus: new crystal-packing contacts in relation to the content of the active site. Acta Crystallogr D Biol Crystallogr 61:218–229CrossRefGoogle Scholar
  33. Schumacher HR, Chen LX (2006) Newer therapeutic approaches: gout. Rheum Dis Clin N Am 32:235–244CrossRefGoogle Scholar
  34. Sepasi Tehrani H et al (2013) Effect of compatible and noncompatible osmolytes on the enzymatic activity and thermal stability of bovine liver catalase. J Biomol Struct Dyn 31:1440–1454CrossRefGoogle Scholar
  35. Shaaban M, Abdelmegeed E, Ali Y (2015) Cloning, expression and purification of recombinant uricase enzyme from Pseudomonas aeruginosa Ps43 using Escherichia coli. J Microbiol Biotechnol 25(6):887–892CrossRefGoogle Scholar
  36. Sharma S, Pathak N, Chattopadhyay K (2012) Osmolyte induced stabilization of protein molecules: a brief review. J Proteins Proteomics 3(2):129–139  Google Scholar
  37. Sherman MR, Saifer MG, Perez-Ruiz F (2008) PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv Drug Deliv Rev 60:59–68CrossRefGoogle Scholar
  38. Street TO, Bolen DW, Rose GD (2006) A molecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci 103:13997–14002CrossRefGoogle Scholar
  39. Wu X, Lee CC, Muzny DM, Caskey CT (1989) Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci 86:9412–9416CrossRefGoogle Scholar
  40. Zhou Y et al (2016) Uricase alkaline enzymosomes with enhanced stabilities and anti-hyperuricemia effects induced by favorable microenvironmental changes. Sci Rep 6:20136. doi: 10.1038/srep20136 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Department of Basic Sciences, Faculty of Veterinary MedicineUrmia UniversityUrmiaIran
  2. 2.Department of Cellular and Molecular Biotechnology, Institute of BiotechnologyUrmia UniversityUrmiaIran

Personalised recommendations